BLOG: Cobra Biologics Reveals New Brand Identity
In January 2020, following the completion of a successful acquisition process, Cobra Biologics became part of the Cognate Bioservices family. In the...
Find Out More
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Providing large scale manufacturing capacity for AZD1222
Find Out More
Cobra Biologics Receives the Queen’s Award for Enterprise in International Trade
The UK’s most prestigious business award granted in recognition of outstanding achievement in the export of services for gene and immunotherapy...
Find Out More
Get In Touch
Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden.
